Globe Newswire

Transaction Enables Company to Preserve ~$2.7 Billion of Net Operating Losses (NOLs)

Rishi Bajaj Appointed Chief Executive Officer; Four New Independent Directors Join Board of Directors

SAN FRANCISCO, April 19, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ: WISH) (“ContextLogic” or the “Company”), today announced that it has completed its previously announced transaction with Qoo10 Pte. Ltd. (“Qoo10”). As disclosed, ContextLogic entered into an... (continue reading...)

Irvine, California, April 19, 2024 (GLOBE NEWSWIRE) -- The DMOS (Demeter Cloud Operating System) project, led by Power Meta Corp’s CTO Chase Donahoe, unveils a revolutionary cloud operating system poised to reshape the decentralized computing landscape. In an exclusive interview, the DMOS Project Leader provided insights into the project's mission, capabilities, and future prospects.

Whether it's powering simple mobile applications or processing complex AI... (continue reading...)

TORONTO and TAMPA, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF), a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market making services, including use of its proprietary algorithm, ICP Premium™, in compliance with the policies and guidelines of the TSX... (continue reading...)

OAKDALE, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Oak Valley Bancorp (NASDAQ: OVLY) (the “Company”), the bank holding company for Oak Valley Community Bank and their Eastern Sierra Community Bank division, recently reported unaudited consolidated financial results for the first quarter of 2024. For the three months ended March 31, 2024, consolidated net income was $5,727,000, or $0.69 per diluted share (EPS). This compared to consolidated net income of... (continue reading...)

FLORHAM PARK, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today that on April 17, 2024, the Company received notification from the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Annual Report on Form... (continue reading...)